(FM) Endocrinología y Nutrición

2018

1. Adipokine dysregulation and adipose tissue inflammation in human obesity

   European Journal of Clinical Investigation, Vol. 48, Núm. 9

2. Adiposidad corporal: un factor de riesgo de hospitalización por gripe menospreciado

   Semergen: revista española de medicina de familia, Núm. 2, pp. 77-78

3. Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis

   Diabetes Therapy, Vol. 9, Núm. 5, pp. 2043-2053

4. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

   Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

5. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

   Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

6. Consenso sobre la evaluación y el tratamiento nutricional de los trastornos de la conducta alimentaria: Anorexia nerviosa, bulimia nerviosa, trastorno por atracón y otros. resumen ejecutivo

   Nutricion Hospitalaria, Vol. 35, Núm. 2, pp. 489-494

7. Consenso sobre la evaluación y el tratamiento nutricional de los trastornos de la conducta alimentaria: anorexia nerviosa

   Nutricion hospitalaria, Vol. 35, Núm. 1, pp. 11-48

8. Consenso sobre la evaluación y el tratamiento nutricional de los trastornos de la conducta alimentaria: bulimia nerviosa, trastorno por atracón y otros

   Nutricion hospitalaria, Vol. 35, Núm. 1, pp. 49-97

9. Consensus on insulin treatment in type 2 diabetes

   Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 1-8

10. Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study

    Clinical Epigenetics, Vol. 10, Núm. 1

11. Executive abstract

    Nutricion Hospitalaria, Vol. 35, Núm. Ext1, pp. 1-9

12. Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment

    Diabetes, Obesity and Metabolism, Vol. 20, Núm. 12, pp. 2860-2868

13. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

    Obesity, Vol. 26, Núm. 4, pp. 672-682

14. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

15. Increased Small Intestine Expression of Non-Heme Iron Transporters in Morbidly Obese Patients With Newly Diagnosed Type 2 Diabetes

    Molecular Nutrition and Food Research, Vol. 62, Núm. 2

16. Mejora en la calidad de vida tras cirugía bariátrica

    Anales del sistema sanitario de Navarra, Vol. 41, Núm. 2, pp. 287-289

17. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development

    Frontiers in immunology, Vol. 9, pp. 2918

18. Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress

    Metabolism: Clinical and Experimental, Vol. 87, pp. 123-135

19. Obesity phenotypes and their paradoxical association with cardiovascular diseases

    European Journal of Internal Medicine, Vol. 48, pp. 6-17

20. Pancreatic aquaporin-7: A novel target for anti-diabetic drugs?

    Frontiers in Chemistry, Vol. 6, Núm. APR